Please visit answersincme.com/HNG860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in weight loss, discusses strategies to optimize therapy for weight loss in patients with type 2 diabetes and obesity. Upon completion of this activity, participants should be better able to: Review key clinical data for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RA in patients with T2D and obesity, and Outline shared decision-making strategies to optimize therapy in patients with T2D and obesity.